Pulmonary eosinophilia associated to treatment with natalizumab

Pulmonary eosinophilia associated to treatment with natalizumab

Natalizumab (Tysabri®) is a leukocytes chemotaxis inhibitor that decreases the leukocytes passage through the hematoencephalic barrier and it is currently used in relapsing-remitting forms of multiple sclerosis (MS). We present a patient with allergic rhinoconjunctivitis diagnosed with MS who starte...

Full description

Bibliographic Details
Main Authors: Elena Curto, Elvira Munteis-Olivas, Eva Balcells, M Marisol Dominguez-Alvarez
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Annals of Thoracic Medicine
Subjects:
Multiple sclerosis
natalizumab
pulmonary eosinophilia
Online Access:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2016;volume=11;issue=3;spage=224;epage=226;aulast=Curto

Internet

http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2016;volume=11;issue=3;spage=224;epage=226;aulast=Curto

Similar Items